Skip to main content
. 2015 Oct-Dec;36(4):219–228. doi: 10.4103/0971-5851.171542

Table 4.

Comparison of the DLTs and recommended doses of S-1 as a single agent in the main Japanese and Western phase I trials

graphic file with name IJMPO-36-219-g006.jpg